We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bath & Body Works Inc | NYSE:BBWI | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.76 | -1.98% | 37.61 | 38.48 | 37.35 | 38.28 | 2,105,347 | 00:37:01 |
Gina Boswell, CEO of Bath & Body Works, commented, “Our strong results exceeded the high end of our net sales and earnings per diluted share guidance. As a result, we are raising our full-year guidance to fully reflect this outperformance.”
Boswell added, "Innovation across our core products, adjacencies, and collaborations is resonating with both new and existing customers supported by the investments we have made in marketing and technology. We are capitalizing on our agile business model and predominantly U.S.-based supply chain, and we believe we are well-positioned to navigate a volatile retail environment and shorter holiday calendar. As we enter the critical holiday period, I am pleased with our strong execution and the momentum we are building, as we drive towards sustainable, long-term profitable growth.”
Third Quarter 2024 Results
The company reported net sales of $1,610 million for the quarter ended November 2, 2024, an increase of 3.0% compared to net sales of $1,562 million for the quarter ended October 28, 2023.
The company reported earnings per diluted share of $0.49 for the third quarter 2024, compared to $0.52 last year. Third quarter operating income was $218 million compared to $221 million last year, and net income was $106 million compared to $119 million last year.
Reported third quarter 2023 results included a $12 million pre-tax gain ($9 million net of tax of $3 million) associated with the early extinguishment of debt. Excluding this item, third quarter 2023 adjusted earnings per diluted share was $0.48 and adjusted net income was $110 million.
At the conclusion of this press release is a reconciliation of reported‐to‐adjusted results, including a description of the adjusted items.
2024 Guidance
The company expects the 13-week fourth quarter 2024 net sales to range between a decline of 6.5% to a decline of 4.5%, compared to $2,912 million for the 14-week fourth quarter 2023. We expect fourth quarter net sales will incur a headwind of approximately 500 basis points due to the shifted fiscal calendar, resulting from and including the extra week in 2023. Fourth quarter earnings per diluted share is expected to be between $1.94 and $2.07, compared to $2.55 in the fourth quarter 2023, and adjusted earnings per diluted share of $2.06 in the fourth quarter 2023.
For fiscal 2024, the company has raised its full-year net sales and earnings guidance from the guidance provided in August. We now expect net sales to range between a decline of 2.5% to a decline of 1.7%, relative to $7,429 million in fiscal 2023. The 53rd week in fiscal 2023 represents a headwind of approximately 100 basis points to net sales change in fiscal 2024. Full-year 2024 earnings per diluted share is now expected to be between $3.46 and $3.59, compared to earnings per diluted share of $3.84 in 2023. Full-year 2024 adjusted earnings per diluted share is now expected to be between $3.15 and $3.28, compared to adjusted earnings per diluted share of $3.27 in fiscal 2023. The company’s full-year guidance includes the anticipated impact of $400 million of cash deployed towards share repurchases.
Earnings Call and Additional Information
Bath & Body Works, Inc. will conduct its third quarter earnings call at 9:00 a.m. Eastern Standard Time on November 25. To listen, call 877-407-9219 (international dial‐in number: 201-689-8852). For an audio replay, call 877-660-6853 (international replay number: 201-612-7415); access code 13749737 or log onto www.BBWInc.com. A slide presentation has been posted on the company’s Investor Relations website that summarizes certain information in the company‘s prepared remarks from the earnings call as well as some additional facts and figures regarding the company’s operating performance and guidance.
ABOUT BATH & BODY WORKS
Home of America’s Favorite Fragrances®, Bath & Body Works is a global leader in personal care and home fragrance, including top-selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Powered by agility and innovation, the company’s predominantly U.S.-based supply chain enables it to deliver quality, on-trend luxuries at affordable prices. Bath & Body Works serves and delights customers however and wherever they want to shop, from welcoming, in-store experiences at more than 1,880 Company-operated Bath & Body Works locations in the U.S. and Canada, more than 500 international franchised locations and an online storefront at bathandbodyworks.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this press release or made by our company or our management involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Words such as “estimate,” “project,” “plan,” “believe,” “expect,” “anticipate,” “intend,” “planned,” “potential,” “target,” “goal” and any similar expressions may identify forward-looking statements. Risks associated with the following factors, among others, in some cases have affected and, in the future, could affect our financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements included in this press release or otherwise made by our company or our management:
We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized. Additional information regarding these and other factors can be found in “Item 1A. Risk Factors” in our 2023 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission, and our subsequent filings.
For further information, please contact:
Bath & Body Works, Inc.: Luke LongInvestorRelations@bbw.com
Media Relations Emmy Beach Communications@bbw.com
BATH & BODY WORKS, INC. | |||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||
(Unaudited) | |||||||||||||||
(In millions, except per share amounts) | |||||||||||||||
Third Quarter | Year-to-Date | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Net Sales | $ | 1,610 | $ | 1,562 | $ | 4,520 | $ | 4,517 | |||||||
Costs of Goods Sold, Buying and Occupancy | (910 | ) | (880 | ) | (2,587 | ) | (2,618 | ) | |||||||
Gross Profit | 700 | 682 | 1,933 | 1,899 | |||||||||||
General, Administrative and Store Operating Expenses | (482 | ) | (461 | ) | (1,345 | ) | (1,310 | ) | |||||||
Operating Income | 218 | 221 | 588 | 589 | |||||||||||
Interest Expense | (77 | ) | (84 | ) | (236 | ) | (259 | ) | |||||||
Other Income | 4 | 22 | 65 | 68 | |||||||||||
Income Before Income Taxes | 145 | 159 | 417 | 398 | |||||||||||
Provision for Income Taxes | 39 | 40 | 72 | 99 | |||||||||||
Net Income | $ | 106 | $ | 119 | $ | 345 | $ | 299 | |||||||
Net Income per Diluted Share | $ | 0.49 | $ | 0.52 | $ | 1.55 | $ | 1.31 | |||||||
Weighted Average Diluted Shares Outstanding | 219 | 228 | 223 | 229 |
BATH & BODY WORKS, INC.CONSOLIDATED CONDENSED BALANCE SHEETS(Unaudited)(In millions) | |||||||
November 2,2024 | October 28,2023 | ||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash and Cash Equivalents | $ | 191 | $ | 412 | |||
Accounts Receivable, Net | 200 | 197 | |||||
Inventories | 1,178 | 1,205 | |||||
Other | 151 | 145 | |||||
Total Current Assets | 1,720 | 1,959 | |||||
Property and Equipment, Net | 1,158 | 1,244 | |||||
Operating Lease Assets | 1,029 | 1,067 | |||||
Goodwill | 628 | 628 | |||||
Trade Name | 165 | 165 | |||||
Deferred Income Taxes | 143 | 35 | |||||
Other Assets | 141 | 145 | |||||
Total Assets | $ | 4,984 | $ | 5,243 | |||
LIABILITIES AND EQUITY (DEFICIT) | |||||||
Current Liabilities: | |||||||
Accounts Payable | $ | 510 | $ | 627 | |||
Accrued Expenses and Other | 547 | 590 | |||||
Current Debt | 314 | — | |||||
Current Operating Lease Liabilities | 188 | 192 | |||||
Income Taxes | 16 | — | |||||
Total Current Liabilities | 1,575 | 1,409 | |||||
Deferred Income Taxes | 45 | 167 | |||||
Long-term Debt | 3,883 | 4,497 | |||||
Long-term Operating Lease Liabilities | 969 | 1,020 | |||||
Other Long-term Liabilities | 260 | 274 | |||||
Total Equity (Deficit) | (1,748 | ) | (2,124 | ) | |||
Total Liabilities and Equity (Deficit) | $ | 4,984 | $ | 5,243 |
BATH & BODY WORKS, INC.CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)(In millions) | |||||||
Year-to-Date | |||||||
2024 | 2023 | ||||||
Operating Activities: | |||||||
Net Income | $ | 345 | $ | 299 | |||
Adjustments to Reconcile Net Income to Net Cash Provided by (Used for) Operating Activities: | |||||||
Depreciation of Long-lived Assets | 211 | 199 | |||||
Share-based Compensation Expense | 31 | 29 | |||||
Gain on Sales of Easton Investments | (39 | ) | — | ||||
Loss (Gain) on Extinguishment of Debt | 3 | (28 | ) | ||||
Deferred Income Taxes | (103 | ) | — | ||||
Changes in Assets and Liabilities: | |||||||
Accounts Receivable | 24 | 29 | |||||
Inventories | (470 | ) | (499 | ) | |||
Accounts Payable, Accrued Expenses and Other | 65 | 117 | |||||
Income Taxes Payable | (124 | ) | (114 | ) | |||
Other Assets and Liabilities | (12 | ) | (4 | ) | |||
Net Cash (Used for) Provided by Operating Activities | (69 | ) | 28 | ||||
Investing Activities: | |||||||
Capital Expenditures | (166 | ) | (250 | ) | |||
Proceeds from Sales of Easton Investments, Net of Fees Paid | 40 | — | |||||
Other Investing Activities | 12 | 11 | |||||
Net Cash Used for Investing Activities | (114 | ) | (239 | ) | |||
Financing Activities: | |||||||
Payments for Long-term Debt | (202 | ) | (343 | ) | |||
Repurchases of Common Stock | (349 | ) | (99 | ) | |||
Dividends Paid | (134 | ) | (137 | ) | |||
Tax Payments related to Share-based Awards | (16 | ) | (10 | ) | |||
Other Financing Activities | (9 | ) | (20 | ) | |||
Net Cash Used for Financing Activities | (710 | ) | (609 | ) | |||
Net Decrease in Cash and Cash Equivalents | (893 | ) | (820 | ) | |||
Cash and Cash Equivalents, Beginning of Year | 1,084 | 1,232 | |||||
Cash and Cash Equivalents, End of Period | $ | 191 | $ | 412 |
BATH & BODY WORKS, INC. | ||||||||||||||
ADJUSTED FINANCIAL INFORMATION | ||||||||||||||
(Unaudited) | ||||||||||||||
(In millions, except per share amounts) | ||||||||||||||
Third Quarter | Year-to-Date | |||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||
Reconciliation of Reported Net Income to Adjusted Net Income | ||||||||||||||
Reported Net Income | $ | 106 | $ | 119 | $ | 345 | $ | 299 | ||||||
Gain on Sales of Easton Investments | — | — | (39 | ) | — | |||||||||
Gain on Extinguishment of Debt | — | (12 | ) | — | (28 | ) | ||||||||
Tax Effect of Adjustments included in Other Income | — | 3 | 14 | 7 | ||||||||||
Tax Benefit from Valuation Allowance Release | — | — | (44 | ) | — | |||||||||
Adjusted Net Income | $ | 106 | $ | 110 | $ | 276 | $ | 278 | ||||||
Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share | ||||||||||||||
Reported Net Income Per Diluted Share | $ | 0.49 | $ | 0.52 | $ | 1.55 | $ | 1.31 | ||||||
Gain on Sales of Easton Investments | — | — | (0.18 | ) | — | |||||||||
Gain on Extinguishment of Debt | — | (0.05 | ) | — | (0.12 | ) | ||||||||
Tax Effect of Adjustments included in Other Income | — | 0.01 | 0.06 | 0.03 | ||||||||||
Tax Benefit from Valuation Allowance Release | — | — | (0.20 | ) | — | |||||||||
Adjusted Net Income Per Diluted Share | $ | 0.49 | $ | 0.48 | $ | 1.24 | $ | 1.21 |
See Notes to Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.
BATH & BODY WORKS, INC. | |||||||
ADJUSTED FORECASTED FINANCIAL INFORMATION | |||||||
(Unaudited) | |||||||
Full-Year | |||||||
2024 | |||||||
Reconciliation of Forecasted Net Income Per Diluted Share to Adjusted Forecasted Net Income Per Diluted Share | |||||||
Low | High | ||||||
Forecasted Net Income Per Diluted Share | $ | 3.46 | $ | 3.59 | |||
Gain on Sales of Easton Investments, Net of Tax | (0.11 | ) | (0.11 | ) | |||
Tax Benefit from Valuation Allowance Release | (0.20 | ) | (0.20 | ) | |||
Adjusted Forecasted Net Income Per Diluted Share | $ | 3.15 | $ | 3.28 |
See Notes to Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.
BATH & BODY WORKS, INC.NOTES TO RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES(Unaudited)
The “Adjusted Financial Information” provided in the attached reflects the following non-GAAP financial measures:
Fiscal 2024
There were no adjustments to results in the third quarter of 2024.
In the second quarter of 2024, adjusted results excludes the following:
There were no adjustments to results in the first quarter of 2024.
Full-year 2024 Adjusted Forecasted Net Income per Diluted Share excludes the adjustments referenced above.
Fiscal 2023
In the third quarter of 2023, adjusted results exclude a:
In the second quarter of 2023, adjusted results exclude a:
In the first quarter of 2023, adjusted results exclude a:
The adjusted financial information should not be construed as an alternative to the results determined in accordance with generally accepted accounting principles. Further, the company’s definitions of adjusted income information may differ from similarly titled measures used by other companies. Management believes that the presentation of adjusted financial information provides additional information to investors to facilitate the comparison of past and present operations. While it is not possible to predict future results, management believes the adjusted financial information is useful for the assessment of the operations of the company because the adjusted items are not indicative of the company’s ongoing operations due to their size and nature. Additionally, management uses adjusted financial information as key performance measures for the purpose of evaluating performance internally. The adjusted financial information should be read in conjunction with the company’s historical financial statements and notes thereto contained in the company’s Quarterly Reports on Form 10-Q and Annual Report on Form 10-K.
BATH & BODY WORKS, INC.Third Quarter 2024 | |||||||||||||||||
Total Sales (In millions): | |||||||||||||||||
Third Quarter | Year-to-Date | ||||||||||||||||
2024 | 2023 | % Change | 2024 | 2023 | % Change | ||||||||||||
Stores - U.S. and Canada (a) | $ | 1,220 | $ | 1,168 | 4.4 | % | $ | 3,425 | $ | 3,345 | 2.4 | % | |||||
Direct - U.S. and Canada | 321 | 317 | 1.5 | % | 879 | 926 | (5.0 | %) | |||||||||
International (b) | 69 | 77 | (11.1 | %) | 216 | 246 | (12.5 | %) | |||||||||
Total Bath & Body Works | $ | 1,610 | $ | 1,562 | 3.0 | % | $ | 4,520 | $ | 4,517 | — | % |
(a) Results include fulfilled buy online-pick up in store orders.
(b) Results include royalties associated with franchised stores and wholesale sales.
Total Company-operated Stores: | ||||||||
Stores | Stores | |||||||
2/3/2024 | Opened | Closed | 11/2/2024 | |||||
United States | 1,739 | 75 | (41 | ) | 1,773 | |||
Canada | 111 | 1 | — | 112 | ||||
Total Bath & Body Works | 1,850 | 76 | (41 | ) | 1,885 |
Total Partner-operated Stores: | ||||||||
Stores | Stores | |||||||
2/3/2024 | Opened | Closed | 11/2/2024 | |||||
International | 454 | 40 | (15 | ) | 479 | |||
International - Travel Retail | 31 | 1 | (1 | ) | 31 | |||
Total International | 485 | 41 | (16 | ) | 510 |
1 Year Bath & Body Works Chart |
1 Month Bath & Body Works Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions